Evans D G, Evans D J, Clegg S
J Clin Microbiol. 1980 Dec;12(6):738-43. doi: 10.1128/jcm.12.6.738-743.1980.
An enzyme-linked immunosorbent assay (ELISA) was employed to detect and quantitate the fimbrial colonization factor antigen (CFA/I) of enterotoxigenic Escherichia coli in stool specimens obtained from adult cases of diarrhea in which CFA/I-positive E. coli was the known causative agent. The inhibition method, or blocking technique, was used. In this method, a standardized dilution of human anti-CFA/I serum was preincubated with dilutions of stool extract before transfer to CFA/I-coated microtiter plate wells, and then ELISA was performed with alkaline phosphatase-conjugated anti-human immunoglobulin. CFA/I purified from E. coli strain H-10407 (O78:H11) was used. Acute-phase diarrheal stool specimens were found to contain approximately 3.0 mg of antigen (mean value) per g stool, whereas control (CFA/I-negative) specimens contained insignificant amounts (less than 0.03 mg/g) of antigen. Also, CFA/I was detected in culture fluids of CFA/I positive enterotoxigenic E. coli belonging to a variety of serotypes and was undetectable in similar preparations from P-strains (spontaneous CFA/I-negative derivatives) of the same test cultures. Equivalent results were obtained in ELISA tests by using bacterial cells taken from isolated colonies grown on CFA agar. These results indicate that the ELISA technique will be useful for the diagnosis of diarrhea caused by CFA/I-positive enterotoxigenic E. coli.
采用酶联免疫吸附测定法(ELISA)检测并定量从已知由CFA/I阳性大肠杆菌引起腹泻的成年患者粪便标本中分离出的产肠毒素大肠杆菌的菌毛定居因子抗原(CFA/I)。使用了抑制法或阻断技术。在该方法中,将标准化稀释的人抗CFA/I血清与粪便提取物的稀释液预孵育,然后转移至包被有CFA/I的微量滴定板孔中,接着用碱性磷酸酶偶联的抗人免疫球蛋白进行ELISA检测。使用从大肠杆菌菌株H-10407(O78:H11)纯化得到的CFA/I。急性期腹泻粪便标本每克粪便中约含3.0毫克抗原(平均值),而对照(CFA/I阴性)标本中抗原含量极少(低于0.03毫克/克)。此外,在多种血清型的CFA/I阳性产肠毒素大肠杆菌的培养液中检测到了CFA/I,而在相同测试培养物的P菌株(自发CFA/I阴性衍生物)的类似制剂中未检测到。通过使用从在CFA琼脂上生长的分离菌落中获取的细菌细胞进行ELISA试验,也得到了相同的结果。这些结果表明,ELISA技术将有助于诊断由CFA/I阳性产肠毒素大肠杆菌引起的腹泻。